Safety of botulinum neurotoxin treatment in patients with chronic anal fissure.
Brisinda
Donatella
D
Maria
Giorgio
G
Fenici
Riccardo
R
Civello
Ignazio Massimo
IM
Brisinda
Giuseppe
G
D000328:Adult; D001337:Autonomic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002908:Chronic Disease; D005401:Fissure in Ano / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D001337:Autonomic Agents; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A